NIFTY HEALTHCARE Index PE Ratio
The NIFTY HEALTHCARE P/E ratio is 52.45 on a market cap weighted basis, derived from the price-to-earnings data of 20 of 20 index constituents with valid EPS. Of these, 0 stocks trade at a low P/E ratio below 15, 3 at moderate valuations between 15 and 25, 7 at elevated earnings multiples between 25 and 50, and 10 at very high valuations above 50. Check NIFTY HEALTHCARE market cap analysis to monitor the combined market capitalisation of all constituents. Use the NIFTY HEALTHCARE PE ratio screener below to analyse the historical valuation trend, EPS distribution, and stock-level price-to-earnings data across all 20 constituents.
NIFTY HEALTHCARE PE Ratio Distribution — Low, Moderate, High & Very High
, 3 moderate (15–25), 7 high (25–50), 10 very high (50+) among 20 NIFTY HEALTHCARE stocks. See NIFTY HEALTHCARE sector weightage analysis to track constituent weightings and sector allocation.
NIFTY HEALTHCARE PE Ratio Historical Trend — 6 Years
Market cap weighted P/E of NIFTY HEALTHCARE over 6 years — 20 stocks with valid EPS, current P/E 52.45. For live index level, EPS data and the full index overview, see NIFTY HEALTHCARE market index details.
NIFTY HEALTHCARE Component Stocks — P/E Ratio & EPS
20 of 20 NIFTY HEALTHCARE constituents with valid P/E — sorted by market cap weight.
| Company | Sector | Market Cap | EPS | PE Ratio |
|---|---|---|---|---|
|
SUNPHARMA
Sun Pharmaceutical
|
Healthcare | ₹4.4 Lakh Cr | ₹45.60 | 41.4 |
|
DIVISLAB
Divis Laboratories
|
Healthcare | ₹1.8 Lakh Cr | ₹96.75 | 73.7 |
|
TORNTPHARM
Torrent Pharmaceuticals
|
Healthcare | ₹1.5 Lakh Cr | ₹63.92 | 70.5 |
|
APOLLOHOSP
Apollo Hospitals
|
Healthcare … | ₹1.2 Lakh Cr | ₹135.04 | 59.3 |
|
CIPLA
Cipla
|
Healthcare | ₹1.1 Lakh Cr | ₹48.03 | 29.6 |
|
DRREDDY
Dr Reddys Laboratories
|
Healthcare | ₹1.1 Lakh Cr | ₹50.41 | 26.7 |
|
ZYDUSLIFE
Zydus Life Science
|
Healthcare | ₹1.1 Lakh Cr | ₹50.09 | 20.4 |
|
LUPIN
Lupin
|
Healthcare | ₹1.0 Lakh Cr | ₹128.45 | 19.3 |
|
MANKIND
Mankind Pharma
|
Healthcare | ₹1.0 Lakh Cr | ₹46.35 | 52.8 |
|
MAXHEALTH
Max Healthcare Institute
|
Healthcare … | ₹96.7K Cr | ₹14.83 | 69.1 |
|
AUROPHARMA
Aurobindo Pharma
|
Healthcare | ₹85.0K Cr | ₹60.34 | 24.3 |
|
LAURUSLABS
Laurus Labs
|
Healthcare | ₹74.1K Cr | ₹16.47 | 81.5 |
|
FORTIS
Fortis Healthcare
|
Healthcare … | ₹73.3K Cr | ₹13.80 | 73.9 |
|
BIOCON
Biocon
|
Healthcare | ₹69.7K Cr | ₹2.82 | 188.7 |
|
GLENMARK
Glenmark Pharmaceuticals
|
Healthcare | ₹66.0K Cr | ₹37.11 | 59.9 |
|
ALKEM
Alkem Laboratories
|
Healthcare | ₹64.1K Cr | ₹181.11 | 26.7 |
|
ABBOTINDIA
Abbott
|
Healthcare | ₹58.9K Cr | ₹730.36 | 37.8 |
|
IPCALAB
IPCA Laboratories
|
Healthcare | ₹40.6K Cr | ₹29.08 | 44.4 |
|
SYNGENE
Syngene International
|
Healthcare | ₹18.8K Cr | ₹7.87 | 58.8 |
|
GRANULES
Granules
|
Healthcare | ₹18.8K Cr | ₹24.47 | 31.3 |
Track NIFTY HEALTHCARE PE Analysis in Your Trading Journal
Use this PE ratio analysis to evaluate index valuation and make informed trading decisions. Monitor how PE trends affect your position sizing and market timing strategies.
Add NIFTY HEALTHCARE Trade to Journal